Company

RyboDyn, Inc.

https://rybodyn.com/

Industrybiotechnology company developing immunotherapies targeting the dark genome

Funding raised

CompanyRoundDate
RyboDyn, Inc.Seed2026-03-24
RyboDyn, Inc.Pre-Seed2025-01-09